Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 15 mg - morphine sulfate extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. limitations of use morphine sulfate extended-release tablets are contraindicated in patients with: prolonged use of opioid analgesics during pregnancy may cause neonatal withdrawal syndrome [see warnings and precautions (5.4)]. there are no available data with morphine sulfate extended-release tablets in pregnant women to inform a drug-associated risk for major birth defects and miscarriage. published studies with morphine use during pregnancy have not reported a clear association with morphine and major birth defects [see human data]. in published animal reproduction studies, morphine administered subcutaneously during the early gestational period produced neural tube defects (i.e., exencephaly and cranioschisis) at 5 and 16 times the human daily dose of 60 mg based on body surface area (hd

Hoa Kỳ - Tiếng Anh - NLM (National Library of Medicine)

american health packaging - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 15 mg - morphine sulfate extended-release tablets are indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. limitations of use - because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses, and because of the greater risks of overdose and death with extended-release opioid formulations, reserve morphine sulfate extended-release tablets for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or immediate-release opioids) are ineffective, not tolerated, or would be otherwise inadequate to provide sufficient management of pain. - morphine sulfate extended-release tablets are not indicated as an as-needed (prn) analgesic. morphine sulfate extended-release tablets are contraindicated in patients with: - significant respiratory depression - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipmen

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

medsurge pharma limited - morphine sulfate pentahydrate 10 mg/ml;   - solution for injection - 10 mg/ml - active: morphine sulfate pentahydrate 10 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

medsurge pharma limited - morphine sulfate pentahydrate 2 mg/ml;   - solution for injection - 2 mg/ml - active: morphine sulfate pentahydrate 2 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

medsurge pharma limited - morphine sulfate pentahydrate 30 mg/ml;   - solution for injection - 30 mg/ml - active: morphine sulfate pentahydrate 30 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

New Zealand - Tiếng Anh - Medsafe (Medicines Safety Authority)

medsurge pharma limited - morphine sulfate pentahydrate 5 mg/ml;   - solution for injection - 5 mg/ml - active: morphine sulfate pentahydrate 5 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - morphine sulfate pentahydrate -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - morphine sulfate pentahydrate -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - morphine sulfate pentahydrate -

Úc - Tiếng Anh - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - morphine sulfate pentahydrate -